Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:26 PM
Ignite Modification Date:
2025-12-25 @ 2:19 PM
NCT ID:
NCT03391466
Group ID:
EG002
Title:
Retreatment Axicabtagene Ciloleucel
Description:
Participants who achieved a partial response or complete response and subsequently experienced disease progression received a second course of conditioning chemotherapy (cyclophosphamide 500 mg/m\^2/day IV infusion and fludarabine 30 mg/m\^2/day IV infusion) for 3 days followed by axicabtagene ciloleucel administered as a single IV infusion at a target dose of 2 x 10\^6 anti-CD 19 CAR transduced autologous T cells/kg.
Deaths Number Affected:
3
Deaths Number At Risk:
None
Serious Number Affected:
2
Serious Number At Risk:
10
Other Number Affected:
10
Other Number At Risk:
10
Study:
NCT03391466
Results Section:
NCT03391466
Adverse Events Module:
NCT03391466